Carmot Therapeutics Competitors and Similar CompaniesClear all
Carmot Therapeutics's competitors and similar companies include Alteogen and CureDM.
 Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Alteogen Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars. | ||
Founding Date | Founding Date 2008 | Founding Date 2008 | Founding Date 2004 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Berkeley, US HQ | Locations Daejeon, KR HQ Seoul, KR | Locations Wilmington, US HQ |
Employees | Employees 109% decrease | Employees 155 | Employees 3 |
Financial | |||
Net income | Net income ($38.8m) (FY, 2022) | Net income ₩145.2b (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 74.8m | Total funding raised N/A | Total funding raised $ 4.6m |
For sources of this data, please see the company profile
View Company Profiles
Alteogen
HQ
Daejeon, KR
Employees
155
Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars.
View company
CureDM
HQ
Wilmington, US
CureDM is a biopharmaceutical company that provides therapies to treat diabetes.
View company